Pelashield® PainGuard® for Skin Graft Donor Site Care
October 2026
Mark Granick, MD, shares his clinical experience using Pelashield® PainGuard® for skin graft donor sites and the difference he has observed in managing donor site pain.
In this video, Dr. Granick discusses his experience with SAMatrix™ Technology with PainGuard®, including product application, patient response, and why Pelashield® PainGuard® has become an important part of his approach to donor site care.
▶️ https://youtu.be/UNF_LM8r8ME(full)
Reducing SSI Risk in High-Risk Orthopedic Surgery Patients with SAMatrix™ Technology
April 30, 2026
What’s working to reduce SSI risk?
In this conversation, Sean M. Griffin, M.D., Board-Certified Orthopaedic Surgeon at Ellis and Badenhausen Orthopaedics, sits down with Brad Wiggins, VP of Clinical Affairs at Imbed Biosciences, to discuss his experience in bringing Surgaflex® into his orthopedic practice.
Dr. Griffin covers what led him to adopt the technology, including a 100-patient SSI-reduction study whose results were enough to change how he approaches infection prevention. He walks through real cases involving total knee and total hip arthroplasty in high-risk patients, sharing how Surgaflex® fits into his protocol where the stakes around infection are highest.
Practical and case-driven, this is a useful watch for orthopedic surgeons weighing the clinical evidence behind Surgaflex® or thinking through how it applies to their own high-risk cases.
▶️ https://youtu.be/9gF4YUZil7A (preview)
▶️ https://youtu.be/SFcYIbhtbSc (full)
OTW Spotlight – Imbed Biosciences
February 4, 2026
In this OTW Spotlight episode, we explore a new approach to surgical site infection prevention that’s delivering remarkable results in orthopedic trauma and high-risk procedures. Brad Wiggins, VP of Clinical Affairs at Imbed Biosciences, and Karen E. Nelson, DO, from the University of Southern Nevada, share how SAMatrix™ (Synthetic Antimicrobial Matrix) technology is transforming wound care outcomes.
Dr. Nelson, a trauma surgeon at a Level 1 trauma center, walks us through her experience treating patients with Surgaflex®, from devastating degloving injuries and open fractures to contaminated wounds that carry high infection risk. She reveals how this fully synthetic matrix made of bioresorbable polymers has become as essential in her OR as saline, and shares striking case studies, including a semi-truck dragging victim whose leg her colleague said “needs to go”, yet healed without infection.
Brad explains what makes Imbed’s SAMatrix™ technology fundamentally different from traditional dressings and antimicrobial powders: it’s an ultra-thin, fully synthetic, and porous matrix that conforms to wound bed microtextures, delivers antimicrobial protection for 72 hours, and completely resorbs — no removal required. He also introduces Surgaflex® with PainGuard®, which incorporates lidocaine for localized pain management, supporting the industry’s move toward opioid-free protocols. Whether you’re an orthopedic surgeon managing complex trauma cases, evaluating alternatives to antibiotic powder protocols, or interested in the latest evidence supporting Imbed Biosciences’ “getting to zero” SSI movement, this episode delivers clinical insights and practical applications you can implement immediately.
A New Solution for Wound Protection and Pain Management:
Surgaflex® with PainGuard®
March 27, 2026
SAMatrix™ is a fully synthetic, ultra-thin, porous matrix composed of bioresorbable polymers. It conforms closely to the wound bed, maintaining a moist healing environment while providing sustained antimicrobial activity. With the addition of PainGuard®, it now also offers acute pain relief. Surgaflex® with PainGuard® is the first wound care matrix to integrate broad-spectrum antimicrobial silver with lidocaine, addressing two major challenges in wound care: infection risk and pain.
Join Damien N. Dauphinee, DPM, FACFAS, FAENS, CWS-P — Reconstructive Foot and Ankle Surgeon, Complete Foot and Ankle Care of North Texas, P.A. and Suhail Sharif, MD — Surgical Oncology Associate Professor of Surgery, TCU/UNT School of Medicine, as they share their real-world clinical experiences, and hear from Gaurav Pranami, PhD, VP, R&D at Imbed Biosciences, about the science that supports this dual-action matrix as an important tool in modern wound management.